Terms: = Germ cell tumor AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Prognosis
344 results:
1. prognosis of glioblastoma patients improves significantly over time interrogating historical controls.
Thomas-Joulié A; Tran S; El Houari L; Seyve A; Bielle F; Birzu C; Lozano-Sanchez F; Mokhtari K; Giry M; Marie Y; Laigle-Donadey F; Dehais C; Houillier C; Psimaras D; Alentorn A; Laurenge A; Touat M; Sanson M; Hoang-Xuan K; Kas A; Rozenblum L; Habert MO; Nichelli L; Leclercq D; Galanaud D; Jacob J; Karachi C; Capelle L; Carpentier A; Mathon B; Belin L; Idbaih A
Eur J Cancer; 2024 May; 202():114004. PubMed ID: 38493668
[TBL] [Abstract] [Full Text] [Related]
2. Challenges and Promise for Glioblastoma Treatment through Extracellular Vesicle Inquiry.
Liguori GL
Cells; 2024 Feb; 13(4):. PubMed ID: 38391949
[TBL] [Abstract] [Full Text] [Related]
3. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
[TBL] [Abstract] [Full Text] [Related]
4. Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.
Vikström S; Syriopoulou E; Andersson TM; Eriksson H
J Am Acad Dermatol; 2024 May; 90(5):963-969. PubMed ID: 38218560
[TBL] [Abstract] [Full Text] [Related]
5. Longer Survival From Melanoma in germany.
Eisemann N; Schumann L; Baltus H; Labohm L; Kraywinkel K; Katalinic A
Dtsch Arztebl Int; 2024 Jan; 121(2):45-51. PubMed ID: 38054977
[TBL] [Abstract] [Full Text] [Related]
6. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
[TBL] [Abstract] [Full Text] [Related]
7. Clinical features and demographic characteristics of gestational trophoblastic neoplasia: Single center experience and the SEER database.
Hou YM; Li PP; Yu H; Feng F; He XY; Chen BH; Li JL; Yao HY; An RF
Biomol Biomed; 2024 Jan; 24(1):176-187. PubMed ID: 37485958
[TBL] [Abstract] [Full Text] [Related]
8. Treatment Outcomes of Childhood Medulloblastoma with the SIOP/UKCCSG PNET-3 Protocol.
Kartal İ; Dağdemir A; Dinçer OS; Şimşek HK; Uygun A; Gürsel ŞB
Indian J Pediatr; 2023 Nov; 90(11):1116-1122. PubMed ID: 37335442
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of surgical treatment of appendix neuroendocrine neoplasms-17 years of single-center experience.
Zhang HW; Jiang Y; Huang ZY; Zhou XC
World J Surg Oncol; 2023 May; 21(1):150. PubMed ID: 37194067
[TBL] [Abstract] [Full Text] [Related]
10. The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
Patuzzo R; Mattavelli I; Gallino G; Galeone C; Valeri B; Mocellin S; Del Fiore P; Ribero S; Mandalà M; Tauceri F; Lombardo M; Maurichi A;
Cancer; 2023 Aug; 129(15):2331-2340. PubMed ID: 37162404
[TBL] [Abstract] [Full Text] [Related]
11. MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa.
Wu HW; Wu CH; Lin SC; Wu CC; Chen HH; Chen YW; Lee YY; Chang FC
Cancer Med; 2023 May; 12(9):10449-10461. PubMed ID: 36916326
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Factors and Outcomes of Cutaneous Malignant Melanoma: A 174-Patient Cohort Study in a Tertiary Hospital in Thailand.
Matrakool P; Chaisrisawadisuk S; Vongviriyangkoon T
Ann Plast Surg; 2023 Jun; 90(6):621-625. PubMed ID: 36880780
[TBL] [Abstract] [Full Text] [Related]
13. Early inflammatory biomarkers and melanoma survival.
Fortes C; Mastroeni S; Zappalà AR; Passarelli F; Ricci F; Abeni D; Michelozzi P
Int J Dermatol; 2023 Jun; 62(6):752-758. PubMed ID: 36872079
[TBL] [Abstract] [Full Text] [Related]
14. Smoking is an Independent Marker of Poor prognosis in Cutaneous Melanoma.
Mattila K; Vihinen H; Karlsson A; Minn H; Vihinen P; Heervä E
Acta Derm Venereol; 2023 Feb; 103():adv00860. PubMed ID: 36748330
[TBL] [Abstract] [Full Text] [Related]
15. Gene Therapy for High Grade Glioma: The Clinical Experience.
Varela ML; Comba A; Faisal SM; Argento A; Franson A; Barissi MN; Sachdev S; Castro MG; Lowenstein PR
Expert Opin Biol Ther; 2023 Feb; 23(2):145-161. PubMed ID: 36510843
[TBL] [Abstract] [Full Text] [Related]
16. Analyzing the role of reoperation in recurrent glioblastoma: a 15-year retrospective study in a single institution.
González V; Brell M; Fuster J; Moratinos L; Alegre D; López S; Ibáñez J
World J Surg Oncol; 2022 Dec; 20(1):384. PubMed ID: 36464682
[TBL] [Abstract] [Full Text] [Related]
17. Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas.
Wu Y; Li H; Tan L; Lai Y; Li Z
Hum Pathol; 2023 Jan; 131():87-97. PubMed ID: 36370822
[TBL] [Abstract] [Full Text] [Related]
18. Surgical treatment confers prognostic significance in pediatric malignant mediastinal germ cell tumors.
Huang TH; Hung GY; Weng TF; Wang FM; Lee CY; Lin DT; Chen BW; Lin KH; Wu KH; Liu HC; Chen JS; Jou ST; Hou JY; Yang YL; Chen SH; Chang HH; Chiou SS; Lin PC; Chen RL; Hsiao CC; Yen HJ; Yang CP; Chang TK; Lu MY; Cheng CN; Sheen JM; Liao YM; Su MY; Yeh TC;
Cancer; 2022 Dec; 128(23):4139-4149. PubMed ID: 36223226
[TBL] [Abstract] [Full Text] [Related]
19. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours.
Hayes AR; Luong TV; Banks J; Shah H; Watkins J; Lim E; Patel A; Grossman AB; Navalkissoor S; Krell D; Caplin ME
J Neuroendocrinol; 2022 Oct; 34(10):e13184. PubMed ID: 36121922
[TBL] [Abstract] [Full Text] [Related]
20. Racial disparities in pediatric malignant glioma management: current state of affairs in the United States.
Lu VM; Niazi TN
J Neurooncol; 2022 Oct; 160(1):171-178. PubMed ID: 36074284
[TBL] [Abstract] [Full Text] [Related]
[Next]
